Trial Profile
Utility of rivaroxaban for chronic disseminated intravascular coagulation
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 May 2016
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Disseminated intravascular coagulation
- Focus Adverse reactions
- 26 May 2016 New trial record